+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beta Interferon"

Beta Interferon - Global Strategic Business Report - Product Thumbnail Image

Beta Interferon - Global Strategic Business Report

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Interferons Global Market Report 2024 - Product Thumbnail Image

Interferons Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • May 2024
  • 78 Pages
  • Global
From
Global Interferons Market 2024-2028 - Product Thumbnail Image

Global Interferons Market 2024-2028

  • Report
  • March 2024
  • 160 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Beta Interferon is a type of biotechnology drug used to treat multiple sclerosis (MS). It is a synthetic form of a naturally occurring protein that helps to reduce inflammation and slow the progression of MS. Beta Interferon is administered through injections and is used to reduce the frequency of MS relapses. It is also used to reduce the severity of symptoms and slow the progression of disability. Beta Interferon is one of the most widely used treatments for MS, and is often prescribed in combination with other therapies. It is also used to treat other neurological conditions, such as chronic inflammatory demyelinating polyneuropathy. The Beta Interferon market is highly competitive, with several major players offering a range of products. Companies in the market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more